Wayback Machine
Nov DEC Jan
Previous capture 21 Next capture
2014 2015 2016
1 captures
21 Dec 15 - 21 Dec 15
sparklines
Close Help
Skip to main content

Access brought to you by: LOCKSS

Login

MD Conference Express
Advanced Search

Main menu

  • HOME
  • BROWSE BY CONFERENCE
  • BROWSE BY DISCIPLINE
    • -- All Disciplines --
    • Anesthesiology
    • Cardiology & Cardiovascular Medicine
    • Dentistry
    • Dermatology
    • Endocrinology, Diabetes & Metabolism
    • Emergency Medicine & Critical Care
    • Hematology
    • Hepatology
    • Infectious Diseases
    • Nephrology
    • Neurology
    • Nutrition
    • Obstetrics & Gynecology
    • Oncology
    • Ophthalmology
    • Orthopaedics & Sports Medicine
    • Psychiatry & Psychology
    • Pulmonary & Respiratory Medicine
    • Radiology
    • Rheumatology
    • Veterinary Medicine
  • ABOUT
    • About Us
    • International Medical Advisory Board
    • Reprints
    • Librarian resources
    • Contact us
    • Help

Demyelinating Diseases

  • Postrelapse MS Treatment with Alemtuzumab Better than SC IFN-β-1a
  • Relapsing-Remitting Multiple Sclerosis Effectively Treated with Peginterferon Beta-1
  • Results of DECIDE: DAC HYP Superior to IFN-β-1a for RRMS
  • Fampridine Prolonged Release Improves Walking Ability and Balance in Patients with Multiple Sclerosis
  • HspB5 Improves MRI Lesions and Clinical Relapse in RRMS
  • Controversies in Multiple Sclerosis Therapy
  • PR—Fampridine Improves Mobility in Patients with MS
  • Treatment with Alemtuzumab Leads to Durable Benefits in Patients with Multiple Sclerosis
  • Improvement in UI with OnabotulinumtoxinA Maintained over 4 Years in Patients with MS
  • Potential Genetic Locus Associated with MS Identified in African Americans

Pages

  • Next
  • 1
  • 2
  • 3

Other Products from SAGE / CQ Press

  • SAGE Journals
  • SAGE Knowledge
  • SAGE Research Methods
  • Help
Copyright © by SAGE Publications
Online ISSN: 1559-8977